Long-Term Survival in Gastroesophageal Junction Adenocarcinoma: Ramucirumab

Long-Term Survival in Gastroesophageal Junction Adenocarcinoma: Ramucirumab

We report a case of long-term survival with complete response of liver metastases within RAINBOW, a randomized, controlled trial of ramucirumab 8 mg/kg intravenously (days 1, 15) versus placebo, both plus paclitaxel 80 mg/m2 intravenously (days 1, 8, 15), every 4 weeks in patients with previously tr...

Full description

Bibliographic Details
Main Authors: Maria Angeles Gil-Delgado, Olivier Lucidarme, Jean Baptiste Bachet, Naima Mahi, David Khayat
Format: Article
Language:English
Published: Karger Publishers 2018-08-01
Series:Case Reports in Gastroenterology
Subjects:
Survival
Gastric cancer
Ramucirumab
Online Access:https://www.karger.com/Article/FullText/490906

Similar Items

Similar Items